Wedmont Private Capital reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,029 shares of the healthcare conglomerate's stock after selling 1,067 shares during the quarter. Wedmont Private Capital's holdings in UnitedHealth Group were worth $3,341,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Alecta Tjanstepension Omsesidigt boosted its stake in shares of UnitedHealth Group by 84.1% during the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 400,500 shares of the healthcare conglomerate's stock valued at $124,880,000 after buying an additional 183,000 shares during the last quarter. Stonekeep Investments LLC lifted its stake in UnitedHealth Group by 7.7% during the second quarter. Stonekeep Investments LLC now owns 946 shares of the healthcare conglomerate's stock worth $295,000 after purchasing an additional 68 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in UnitedHealth Group by 5.7% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 365,617 shares of the healthcare conglomerate's stock worth $114,062,000 after purchasing an additional 19,700 shares during the last quarter. Sunflower Bank N.A. lifted its stake in UnitedHealth Group by 8.1% in the second quarter. Sunflower Bank N.A. now owns 1,888 shares of the healthcare conglomerate's stock valued at $589,000 after buying an additional 142 shares during the last quarter. Finally, Chickasaw Capital Management LLC lifted its stake in UnitedHealth Group by 358.3% in the second quarter. Chickasaw Capital Management LLC now owns 9,133 shares of the healthcare conglomerate's stock valued at $2,849,000 after buying an additional 7,140 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Bank of America raised their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. KeyCorp lowered their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sanford C. Bernstein lifted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Finally, Piper Sandler lowered their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
View Our Latest Stock Analysis on UNH
UnitedHealth Group Stock Up 0.6%
Shares of NYSE UNH traded up $1.90 during mid-day trading on Friday, reaching $336.72. 13,528,738 shares of the company's stock were exchanged, compared to its average volume of 13,748,202. The business has a fifty day simple moving average of $295.67 and a 200 day simple moving average of $364.42. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market capitalization of $304.96 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 2.20 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 earnings per share. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.